Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma
- PMID: 20953896
- DOI: 10.1007/s11060-010-0435-y
Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma
Abstract
Intrathecal application of liposomal cytarabine (Ara-C) (DepoCyte(®)) has been associated with neurotoxicity when applied as part of a polychemotherapy regimen. Patients with primary central nervous system lymphoma treated with high-dose systemic methotrexate (MTX)- and Ara-C-based polychemotherapy including six cycles of liposomal Ara-C (50 mg intrathecally every 3 weeks) were prospectively monitored for neurotoxic side-effects. Between November 2005 and February 2009, 149 intrathecal applications of liposomal cytarabine (DepoCyte(®)) were carried out in 33 patients, 7 (21%) of whom developed an incomplete conus medullaris/cauda equina syndrome with incontinence for bladder (6) and bowel function (3) or lumbosacral polyradicular paresis (1), resolving only incompletely over a follow-up period of 9-30 months. In six of these seven patients, lumbosacral magnetic resonance imaging (MRI) was negative for leptomeningeal infiltration or arachnoiditis. Cerebrospinal fluid (CSF) analysis performed in six of these seven patients showed normal cell count in all and increased total protein in four of them. One patient among these seven suffered a seizure without other identifiable causes. Conus/cauda syndrome has to be considered as a serious potential neurotoxic side-effect in patients receiving liposomal Ara-C as part of a multimodal regimen including high-dose systemic MTX and Ara-C.
Similar articles
-
Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.J Neurooncol. 2011 Jul;103(3):603-9. doi: 10.1007/s11060-010-0428-x. Epub 2010 Oct 17. J Neurooncol. 2011. PMID: 20953897
-
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.Blood. 2007 Apr 15;109(8):3214-8. doi: 10.1182/blood-2006-08-043646. Epub 2007 Jan 5. Blood. 2007. PMID: 17209054 Clinical Trial.
-
Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.J Pediatr Hematol Oncol. 2007 Apr;29(4):222-6. doi: 10.1097/MPH.0b013e318041f112. J Pediatr Hematol Oncol. 2007. PMID: 17414563
-
Intrathecal chemotherapy with antineoplastic agents in children.Paediatr Drugs. 2001;3(4):237-46. doi: 10.2165/00128072-200103040-00001. Paediatr Drugs. 2001. PMID: 11354696 Review.
-
Excessive spinal cord toxicity from intensive central nervous system-directed therapies.Cancer. 1994 Dec 1;74(11):3034-41. doi: 10.1002/1097-0142(19941201)74:11<3034::aid-cncr2820741122>3.0.co;2-o. Cancer. 1994. PMID: 7954266 Review.
Cited by
-
Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.PLoS One. 2012;7(11):e48752. doi: 10.1371/journal.pone.0048752. Epub 2012 Nov 13. PLoS One. 2012. PMID: 23152799 Free PMC article.
-
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group.Haematologica. 2015 Apr;100(4):534-40. doi: 10.3324/haematol.2014.108472. Epub 2014 Dec 5. Haematologica. 2015. PMID: 25480497 Free PMC article. Clinical Trial.
-
Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.Front Pediatr. 2017 May 15;5:105. doi: 10.3389/fped.2017.00105. eCollection 2017. Front Pediatr. 2017. PMID: 28555178 Free PMC article. Review.
-
Post-intrathecal chemotherapy-related paraplegia syndrome in hematological cancer patients: A systematic review.Neurooncol Adv. 2024 Dec 20;7(1):vdae217. doi: 10.1093/noajnl/vdae217. eCollection 2025 Jan-Dec. Neurooncol Adv. 2024. PMID: 39791016 Free PMC article.
-
Acute painful lumbosacral paresthesia after intrathecal rituximab.J Neurol. 2012 Mar;259(3):559-61. doi: 10.1007/s00415-011-6190-y. Epub 2011 Aug 10. J Neurol. 2012. PMID: 21830092 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical